Correction to: CAR NK cell therapy for solid tumors: potential and challenges
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmune Cell Function and Interaction · CAR-T cell therapy research · Phagocytosis and Immune Regulation
Correction to:
Yanlin Yu, Mitchell Ho, CAR NK cell therapy for solid tumors: potential and challenges, Antibody Therapeutics, Volume 8, Issue 4, October 2025, Pages 275–289, https://doi.org/10.1093/abt/tbaf019
The originally published version of this manuscript has been corrected to address an error in Figure 1.
Correction Details:
In the right-hand panel of Figure 1, the label “ITAM” was incorrectly used and has been changed to the correct term, “ITIM”.